Michael Holick~~Sean Dougherty~~Sophie Staples~~Andrew Mandelbaum~~Jeannine McSweeney~~Joshua Stephens~~Vanessa Burrows~~Alysha Sekhon~~Krista McManus~~Timothy Mulvihill~~Steven DeLott
January 24, 2026
Laborie to Acquire Urotronic

1 min
AI-made summary
- Laborie Medical Technologies, Inc., a Patricia Industries portfolio company, has entered into a definitive agreement to acquire Urotronic, Inc
- for an upfront cash payment of $255 million and up to $345 million in potential milestone payments, with the transaction expected to close in the fourth quarter of 2023
- Laborie will also make a $5 million strategic equity investment in GIE Medical, Inc., a company developing drug-coated balloon technology for gastrointestinal tract strictures.
The Firm is representing Laborie Medical Technologies, Inc., a Patricia Industries portfolio company, in connection with its definitive agreement to acquire Urotronic, Inc. The transaction consists of an upfront cash payment of $255 million and up to an additional $345 million in potential commercial and reimbursement milestone payments. The transaction is expected to be completed during the fourth quarter 2023.~~In conjunction with the Urotronic acquisition, Laborie will also make a $5 million strategic equity investment into GIE Medical, Inc., a clinical stage company spun out of Urotronicm which is developing drug-coated balloon technology for treatment of strictures within the gastrointestinal tract which could, like Optilume urethral strictures, offer a highly differentiated and innovative solution for treatment of these conditions.~~Urotronic, headquartered in Plymouth, Minnesota, is a medical device company currently conducting clinical trials to support global commercialization of their products. The Optilume® drug-coated balloon technology provides a minimally invasive treatment option for men suffering from urinary tract conditions like urethral strictures and benign prostatic hyperplasia. The drug-coated balloon technology creates a paradigm change from the methods currently used by urologists to treat these conditions.~~Headquartered in Portsmouth, New Hampshire, Laborie is a global medical technology company focused on Urology, Urogynecology, Gastroenterology, Obstetrics, Gynecology & Neonatal Health. Laborie manufactures and delivers high-quality, high-impact diagnostic and therapeutic products that help clinicians and hospitals preserve and restore patient dignity.~~Patricia Industries is a long-term owner that invests in companies and works to develop each company to its full potential. Patricia Industries is a part of the industrial holding company Investor AB, whose main owner is the Wallenberg Foundations.~~The Simpson Thacher team includes Michael T. Holick and Daniel Lee (M&A); Sean Dougherty and Rachel Lerman (Capital Markets); Sophie Staples and Andrew Mandelbaum (Tax); Jeannine McSweeney and Joshua Stephens (ECEB); Vanessa Burrows and Nawa Lodin (Healthcare); Alysha Sekhon (Intellectual Property); Krista McManus (Real Estate); Timothy Mulvihill (Environmental); and Steven DeLott (Insurance).
Article Author
Michael Holick~~Sean Dougherty~~Sophie Staples~~Andrew Mandelbaum~~Jeannine McSweeney~~Joshua Stephens~~Vanessa Burrows~~Alysha Sekhon~~Krista McManus~~Timothy Mulvihill~~Steven DeLott
The Sponsor
